Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases.
Mertz P, Chalayer E, Amoura Z, Cathebras P, Chiche L, Coestedoat N, Deroux A, Diot E, Durupt S, Forestier E, Gorse A, Hudier L, Killian M, Lambotte O, Lecomte C, Ledoult E, Martinez C, Mathian A, Morin AS, Noel N, Pineton De Chambrun M, Terriou L, Sibilia J, Gottenberg JE, Korganow AS, Arnaud L, Martin T. Mertz P, et al. Among authors: killian m. Haematologica. 2021 Mar 1;106(3):871-874. doi: 10.3324/haematol.2020.249896. Haematologica. 2021. PMID: 32467142 Free PMC article. No abstract available.
[Myelofibrosis: A review].
Genthon A, Killian M, Mertz P, Cathebras P, Gimenez De Mestral S, Guyotat D, Chalayer E. Genthon A, et al. Among authors: killian m. Rev Med Interne. 2021 Feb;42(2):101-109. doi: 10.1016/j.revmed.2020.08.018. Epub 2020 Nov 23. Rev Med Interne. 2021. PMID: 33243417 Review. French.
JAK1/2 Inhibition in Severe TAFRO Syndrome: A Case Report.
Killian M, Viel S, Chalayer E, Forest F, Grange S, Bonnefoy PB, Oksenhendler E, Cathébras P, Paul S. Killian M, et al. Ann Intern Med. 2021 May;174(5):719-721. doi: 10.7326/L20-1051. Epub 2021 Jan 12. Ann Intern Med. 2021. PMID: 33428440 No abstract available.
Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel disease.
Tournier Q, Paul S, Williet N, Berger AE, Veyrard P, Boschetti G, Le Roy B, Killian M, Phelip JM, Flourie B, Nancey S, Roblin X. Tournier Q, et al. Among authors: killian m. Aliment Pharmacol Ther. 2021 Jun;53(11):1190-1200. doi: 10.1111/apt.16333. Epub 2021 Apr 19. Aliment Pharmacol Ther. 2021. PMID: 33872404
443 results